Hypercholesterolemia Clinical Trial
Official title:
Open Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement of LDL Goals. - Denmark
Verified date | March 2009 |
Source | AstraZeneca |
Contact | n/a |
Is FDA regulated | No |
Health authority | Denmark: Danish Medicines Agency |
Study type | Interventional |
The purpose of the study is to determine whether an Internet based compliance tool is superior to common diet counselling in patients with hypercholesterolemia.
Status | Withdrawn |
Enrollment | 1175 |
Est. completion date | |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Available personal mailbox and access to the Internet - Primary hypercholesterolemia with CV risk > 20% over 10 years judged by the investigator or a history of ischemic heart disease or other established atherosclerotic disease (claudicatio intermittens, apoplexia cerebri (ischaemic stroke)) or stable diabetes mellitus - Fasting LDL-C level > 3.2 mmol/L Exclusion Criteria: - Known heterozygous or homozygous familial hypercholesterolemia or known type III hyperlipoproteinaemia (familial dysbetalipoproteinaemia) - Documented secondary hypercholesterolemia of any cause except stable diabetes mellitus (type 1 or type 2) - History of serious adverse effect or hypersensitivity reactions to statins, in particular any history of myopathy |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Denmark | Research Site | Aabenraa | |
Denmark | Research Site | Aalbaek | |
Denmark | Research Site | Aalborg | |
Denmark | Research Site | Aarhus C | |
Denmark | Research Site | Aerup | |
Denmark | Research Site | Albertslund | |
Denmark | Research Site | Ålestrup | |
Denmark | Research Site | Ans by | |
Denmark | Research Site | Bagsvaerd | |
Denmark | Research Site | Billund | |
Denmark | Research Site | Birkeroed | |
Denmark | Research Site | Broby | |
Denmark | Research Site | Broendby Strand | |
Denmark | Research Site | Broenshoej | |
Denmark | Research Site | Copenhagen V | |
Denmark | Research Site | Elsingore | |
Denmark | Research Site | Farum | |
Denmark | Research Site | Fredericia | |
Denmark | Research Site | Frederiksberg C | |
Denmark | Research Site | Frederikshavn | |
Denmark | Research Site | Frederikssund | |
Denmark | Research Site | Gentofte | |
Denmark | Research Site | Glesborg | |
Denmark | Research Site | Glostrup | |
Denmark | Research Site | Goerlev Sjaelland | |
Denmark | Research Site | Grenå | |
Denmark | Research Site | Greve | |
Denmark | Research Site | Grindsted | |
Denmark | Research Site | Haarlev | |
Denmark | Research Site | Hadsund | |
Denmark | Research Site | Haslev | |
Denmark | Research Site | Hedehusene | |
Denmark | Research Site | Hellerup | |
Denmark | Research Site | Helsinge | |
Denmark | Research Site | Herning | |
Denmark | Research Site | Hilleroed | |
Denmark | Research Site | Hoeng | |
Denmark | Research Site | Hoersholm | |
Denmark | Research Site | Holbaek | |
Denmark | Research Site | Hornbaek | |
Denmark | Research Site | Horsens | |
Denmark | Research Site | Humlebaek | |
Denmark | Research Site | Hvidovre | |
Denmark | Research Site | Ikast | |
Denmark | Research Site | Jaegerspris | |
Denmark | Research Site | Kalundborg | |
Denmark | Research Site | Karlslunde | |
Denmark | Research Site | Kastrup | |
Denmark | Research Site | Kgs. Lyngby | |
Denmark | Research Site | Kjellerup | |
Denmark | Research Site | Kokkedal | |
Denmark | Research Site | Kolding | |
Denmark | Research Site | Kvaerndrup | |
Denmark | Research Site | Langeskov, Fyn | |
Denmark | Research Site | Lyngby | |
Denmark | Research Site | Lystrup | |
Denmark | Research Site | Maeloev | |
Denmark | Research Site | Middelfart | |
Denmark | Research Site | Morud | |
Denmark | Research Site | Naerum | |
Denmark | Research Site | Naestved | |
Denmark | Research Site | Noerre Alslev | |
Denmark | Research Site | Noerresundby | |
Denmark | Research Site | Nyborg | |
Denmark | Research Site | Nykoebing F | |
Denmark | Research Site | Odense C | |
Denmark | Research Site | Odense NV | |
Denmark | Research Site | Oelstykke | |
Denmark | Research Site | Oksboel | |
Denmark | Research Site | Randers | |
Denmark | Research Site | Risskov | |
Denmark | Research Site | Roedovre | |
Denmark | Research Site | Roskilde | |
Denmark | Research Site | Roslev | |
Denmark | Research Site | Rudkoebing | |
Denmark | Research Site | Rungsted Kyst | |
Denmark | Research Site | Saeby | |
Denmark | Research Site | Sakskoebing | |
Denmark | Research Site | Saltum | |
Denmark | Research Site | Skals | |
Denmark | Research Site | Skive | |
Denmark | Research Site | Skovlunde | |
Denmark | Research Site | Slagelse | |
Denmark | Research Site | Snekkersten | |
Denmark | Research Site | Soenderborg | |
Denmark | Research Site | Soendersoe | |
Denmark | Research Site | Solroed Strand | |
Denmark | Research Site | Soroe | |
Denmark | Research Site | Stege | |
Denmark | Research Site | Stenlille | |
Denmark | Research Site | Struer | |
Denmark | Research Site | Svendborg | |
Denmark | Research Site | Svendstrup | |
Denmark | Research Site | Taastrup | |
Denmark | Research Site | Thorsoe | |
Denmark | Research Site | Toelloese | |
Denmark | Research Site | Toender | |
Denmark | Research Site | Ullerslev | |
Denmark | Research Site | Vaerloese | |
Denmark | Research Site | Vanloese | |
Denmark | Research Site | Varde | |
Denmark | Research Site | Vedbaek | |
Denmark | Research Site | Vejle | |
Denmark | Research Site | Viborg | |
Denmark | Research Site | Viby J | |
Denmark | Research Site | Vinderup | |
Denmark | Research Site | Virum | |
Denmark | Research Site | Viuf | |
Denmark | Research Site | Vojens |
Lead Sponsor | Collaborator |
---|---|
AstraZeneca |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The primary endpoint is the number and percentage of subjects from each group (rosuvastatin or rosuvastatin + a compliance enhancement tool) who reached the DSAM LDL-C target goal (LDL-C < 3.0 mmol/L) after 6 months therapy (24 weeks). | |||
Secondary | Number and percentage of subjects within the DSAM LDL-C target goal after 3 months therapy | |||
Secondary | Compliance with study drug assessed by tablet count data | |||
Secondary | Number and percentage of subjects increasing rosuvastatin dosage from 10 mg to 20 mg at week 12 | |||
Secondary | Percentage change in TC, HDL-C, LDL-C, TG from week 0 to week 24 | |||
Secondary | Change in weight after 6 months therapy | |||
Secondary | Change in waistline after 6 months therapy |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Recruiting |
NCT03947866 -
Ezetimibe-Rosuvastatin Evaluation Study
|
||
Completed |
NCT01709513 -
Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)
|
Phase 3 | |
Completed |
NCT01212900 -
Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression
|
Phase 4 | |
Completed |
NCT00001154 -
Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
|
||
Completed |
NCT02550288 -
A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)
|
Phase 3 | |
Completed |
NCT03929198 -
Translation of Pritikin Program to the Community
|
N/A | |
Completed |
NCT04485793 -
Effect of a Dietary Supplement on Lipid Pattern and Liver Parameters in Hypercholesterolemia
|
N/A | |
Completed |
NCT02341924 -
Validating the "Foods for Health" Portfolio of Functional Food Products
|
N/A | |
Active, not recruiting |
NCT02223793 -
Vascular Lifestyle-Intervention and Screening in Pharmacy
|
N/A | |
Completed |
NCT01934608 -
The Effect of Synching Prescription Refills on Adherence
|
N/A | |
Completed |
NCT01941836 -
Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients
|
Phase 2 | |
Recruiting |
NCT01705873 -
Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen
|
N/A | |
Completed |
NCT01670734 -
Pharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01678521 -
Effect of LDL-apheresis on PTX3 Plasma Levels in Hypercholesterolemic Patients
|
N/A | |
Completed |
NCT01370590 -
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)
|
Phase 3 | |
Completed |
NCT01370603 -
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)
|
Phase 3 | |
Completed |
NCT01446679 -
Special Drug Use-Results Survey of Lipitor Tablets
|
N/A | |
Completed |
NCT01768403 -
Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia
|
N/A | |
Completed |
NCT01478789 -
Efficacy of Plant Sterol-Fortified Dairy Product on Plasma Lipid and Plant Sterol Concentrations in Humans
|
N/A |